Chengdu Olymvax Biopharmaceuticals Inc.

SHSE:688319 Rapport sur les actions

Capitalisation boursière : CN¥4.2b

Chengdu Olymvax Biopharmaceuticals Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Shaowen Fan

Directeur général

CN¥713.5k

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général14.8yrs
Propriété du PDG3.9%
Durée moyenne d'occupation des postes de directionpas de données
Durée moyenne du mandat des membres du conseil d'administration8.4yrs

Mises à jour récentes de la gestion

Recent updates

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Oct 09
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

Sep 30
We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Jun 24
What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

May 28
Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Apr 18
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

Mar 26
These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

PDG

Shaowen Fan (71 yo)

14.8yrs

Titularisation

CN¥713,500

Compensation

Mr. Shaowen Fan is Chairman of the Board & GM of Chengdu Olymvax Biopharmaceuticals Inc. from January 2010. Mr. Fan joined the Chengdu Olymvax Biopharmaceuticals Inc. in 2010.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Shaowen Fan
Chairman of the Board & GM14.8yrsCN¥713.50k3.86%
CN¥ 161.1m
Yunhui Yu
Director11.4yrsCN¥42.00k0.014%
CN¥ 575.9k
Pengfei Zhang
Chairman of Supervisory Board8.4yrspas de données6.38%
CN¥ 266.2m
Fan Fan
Executive Deputy GM & Vice Chairman of the Board14.8yrsCN¥633.20k7.53%
CN¥ 314.3m
Cheng Hu
Director2.5yrsCN¥42.00k1.64%
CN¥ 68.5m
Aimin Chen
Director14.8yrsCN¥602.00k0.15%
CN¥ 6.3m
Lu Lu
Employee Representative Director2.5yrsCN¥195.00k0.067%
CN¥ 2.8m
Shao Ping He
Independent Director5.6yrsCN¥83.90kpas de données
Hua Yan
Supervisor2.5yrspas de données0.20%
CN¥ 8.4m

8.4yrs

Durée moyenne de l'emploi

61yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 688319 sont considérés comme expérimentés (ancienneté moyenne 8.4 ans).